Cargando…
Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C
As the COVID-19 pandemic continues, researchers seek to identify efficacious treatments. Current approaches to COVID-19 therapeutics focus on antiviral agents, convalescent plasma, monoclonal antibodies, immunomodulators and more traditional therapies such as steroids [1], [2], [3], [4], [5], [6]. R...
Autor principal: | Pestka, Steven B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884230/ https://www.ncbi.nlm.nih.gov/pubmed/33647606 http://dx.doi.org/10.1016/j.mehy.2021.110537 |
Ejemplares similares
-
Teaching Old Drugs New Tricks: Statins for COVID-19?
por: Fajgenbaum, David C., et al.
Publicado: (2020) -
Treatment of COVID-19: old tricks for new challenges
por: Cunningham, Anne Catherine, et al.
Publicado: (2020) -
Doxycycline: new tricks for an old drug
por: Barbie, David A., et al.
Publicado: (2015) -
Ivermectin – Old Drug, New Tricks?
por: Laing, Roz, et al.
Publicado: (2017) -
Methotrexate an Old Drug with New Tricks
por: Bedoui, Yosra, et al.
Publicado: (2019)